Crossmark

Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12879-024-10227-0

Published Online: 2025-01-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alshehri, Abdulmajeed M.

Al Yami, Majed S.

Aldairem, Atheer

Alfehaid, Lama

Almutairi, Abdulaali R.

Almohammed, Omar A.

Badawoud, Amal Mohammad
Funding

Funding for this research was provided by:

Princess Nourah bint Abdulrahman University Researchers Supporting Project, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia (PNURSP2024R418)
License Information

Text and Data Mining valid from 2025-01-07

Version of Record valid from 2025-01-07
More Information

Article History

Received: 9 August 2024

Accepted: 14 November 2024

First Online: 7 January 2025

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below